Evidence map›Paper›PMID 34111964›Full record

ReviewThe British journal of radiology2021

Cumulative radiation doses from recurrent PET-CT examinations.

Makoto Hosono, Mamoru Takenaka, Hajime Monzen, Mikoto Tamura, Masatoshi Kudo, Yasumasa Nishimura

Abstract readReview
In one paragraph

Review in The British journal of radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Diagnostic impact of 18F-FDG PET/MRI over PET/CT in histiocytoses: a prospective comparative study.European journal of nuclear medicine and molecular imaging · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Perfluoro-JACS Au · 2025
    Article
  14. Article
  15. Automated Measurement of Effective Radiation Dose byTomography (Ann Arbor, Mich.) · 2024
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Patients undergoing multipleThe British journal of radiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Makoto HosonoDepartment of Radiation Oncology, Faculty of Medicine, Kindai University, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, Japan.ORCID 0000-0001-8040-3245
Mamoru TakenakaDepartment of Gastroenterology, Faculty of Medicine, Kindai University, Ohno-Higashi, Osaka-Sayama, Osaka, Japan.
Hajime Monzen. Department of Medical Physics, Graduate School of Medical Sciences, Kindai University, Ohno-Higashi, Osaka-Sayama, Osaka, Japan.
Mikoto Tamura. Department of Medical Physics, Graduate School of Medical Sciences, Kindai University, Ohno-Higashi, Osaka-Sayama, Osaka, Japan.
Masatoshi KudoDepartment of Gastroenterology, Faculty of Medicine, Kindai University, Ohno-Higashi, Osaka-Sayama, Osaka, Japan.
Yasumasa NishimuraDepartment of Radiation Oncology, Faculty of Medicine, Kindai University, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Positron emission tomography (PET-CT) is an essential imaging modality for the management of various diseases. Increasing numbers of PET-CT examinations are carried out across the world and deliver benefits to patients; however, there are concerns about the cumulative radiation doses from these examinations in patients. Compared to the radiation exposure delivered by CT, there have been few reports on the frequency of patients with a cumulative effective radiation dose of ≥100 mSv from repeated PET-CT examinations. The emerging dose tracking system facilitates surveys on patient cumulative doses by PET-CT because it can easily wrap up exposure doses of PET radiopharmaceuticals and CT. Regardless of the use of a dose tracking system, implementation of justification for PET-CT examinations and utilisation of dose reduction measures are key issues in coping with the cumulative dose in patients. Despite all the advantages of PET/MRI such as eliminating radiation exposure from CT and providing good tissue contrast in MRI, it is expensive and cannot be introduced at every facility; thus, it is still necessary to utilise PET-CT with radiation reduction measures in most clinical situations.

Indexed as

Positron Emission Tomography Computed TomographyRadiation DosageFluorodeoxyglucose F18HumansRadiation InjuriesRadiation MonitoringRadiation ProtectionRadiopharmaceuticalsRetreatmentRisk FactorsFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID34111964
PMCPMC9328066

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.